Improved Synthesis of the Selective Rho-Kinase Inhibitor 6-Chloro-N4-{3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl}pyrimidin-2,4-diamine

被引：13

作者：

Schirok, Hartmut ^{[1
]}

Paulsen, Holger ^{[1
]}

Kroh, Walter ^{[1
]}

Chen, Gang ^{[2
]}

Gao, Ping ^{[2
]}

机构：

[1] Bayer Schering Pharma AG, Med Chem Wuppertal, D-42096 Wuppertal, Germany

[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China

来源：

ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2010年 / 14卷 / 01期

关键词：

EMBRYONIC STEM-CELLS; VASCULAR SMOOTH-MUSCLE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; POTENTIAL THERAPEUTIC TARGET; ORGANIC FLUORINE-COMPOUNDS; BINDING PROTEIN RHO; POSTMARKETING SURVEILLANCE; CARDIOVASCULAR-DISEASES; MYOSIN PHOSPHATASE; ROCK INHIBITORS;

D O I：

10.1021/op900260k

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

A highly potent and selective Rho-kinase inhibitor containing a 7-azaindole moiety has been developed at Bayer Schering Pharma. Herein we disclose details of a significantly improved synthesis of the compound in 8.2% overall yield. Key aspects include cost and safety considerations and the uncommon use of a trifluoromethyl group with controllable reactivity as a masked methyl group.

引用

页码：168 / 173

页数：6

共 82 条

[31] Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges [J].

Hu, E ;

Lee, D .

EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (04) :715-736

[32] The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase [J].

Ishizaki, T ;

Maekawa, M ;

Fujisawa, K ;

Okawa, K ;

Iwamatsu, A ;

Fujita, A ;

Watanabe, N ;

Saito, Y ;

Kakizuka, A ;

Morii, N ;

Narumiya, S .

EMBO JOURNAL, 1996, 15 (08) :1885-1893

[33] PYRROLE STUDIES .30. A CRITICAL-EVALUATION OF THE KNORR SYNTHESIS OF TRIFLUOROMETHYLPYRROLES AND THE REACTIVITY OF DIETHYL 4-TRIFLUOROMETHYL-2-METHYLPYRROLE-3,5-DICARBOXYLATE [J].

JONES, RA ;

RUSTIDGE, DC ;

CUSHMAN, SM .

SYNTHETIC COMMUNICATIONS, 1984, 14 (06) :575-584

[34] Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase [J].

Kast, R. ;

Schirok, H. ;

Figueroa-Perez, S. ;

Mittendorf, J. ;

Gnoth, M. J. ;

Apeler, H. ;

Lenz, J. ;

Franz, J. K. ;

Knorr, A. ;

Huetter, J. ;

Lobell, M. ;

Zimmermann, K. ;

Muenter, K. ;

Augstein, K. H. ;

Ehmke, H. ;

Stasch, J. P. .

BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (07) :1070-1080

[35] ACTIVATION OF CARBON FLUORINE BONDS BY METAL-COMPLEXES [J].

KIPLINGER, JL ;

RICHMOND, TG ;

OSTERBERG, CE .

CHEMICAL REVIEWS, 1994, 94 (02) :373-431

[36] Synthesis of polysubstituted 4-fluoroquinolinones [J].

Kiselyov, AS ;

Piatnitski, EL ;

Doody, J .

ORGANIC LETTERS, 2004, 6 (22) :4061-4063

[37] Hydrodefluorination of non-activated C-F bonds by diisobutyl-aluminiumhydride via the aluminium cation [i-Bu2Al]+ [J].

Klahn, Marcus ;

Fischer, Christine ;

Spannenberg, Anke ;

Rosenthal, Uwe ;

Krossing, Ingo .

TETRAHEDRON LETTERS, 2007, 48 (50) :8900-8903

[38] STUDIES ON ORGANIC FLUORINE-COMPOUNDS .14. SYNTHESES AND REACTIONS OF (TRIFLUOROMETHYL)INDOLES [J].

KOBAYASH.Y ;

KUMADAKI, I ;

HIROSE, Y ;

HANZAWA, Y .

JOURNAL OF ORGANIC CHEMISTRY, 1974, 39 (13) :1836-1838

[39]

KOBAYASHI Y, 1984, CHEM PHARM BULL, V32, P4402

[40] Pathogenesis of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage: Putative Mechanisms and Novel Approaches [J].

Kolias, Amgelos G. ;

Sen, Jon ;

Belli, Antonio .

JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (01) :1-11

← 1 2 3 4 5 6 7 8 9 →